The Landscape of PDK1 in Breast Cancer

Given that 3-phosphoinositide-dependent kinase 1 (PDK1) plays a crucial role in the malignant biological behaviors of a wide range of cancers, we review the influence of PDK1 in breast cancer (BC). First, we describe the power of PDK1 in cellular behaviors and characterize the interaction networks o...

Full description

Bibliographic Details
Main Authors: Na Wang, Jianjiang Fu, Zhihua Li, Ningni Jiang, Yanhong Chen, Juan Peng
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/3/811
_version_ 1797488648032092160
author Na Wang
Jianjiang Fu
Zhihua Li
Ningni Jiang
Yanhong Chen
Juan Peng
author_facet Na Wang
Jianjiang Fu
Zhihua Li
Ningni Jiang
Yanhong Chen
Juan Peng
author_sort Na Wang
collection DOAJ
description Given that 3-phosphoinositide-dependent kinase 1 (PDK1) plays a crucial role in the malignant biological behaviors of a wide range of cancers, we review the influence of PDK1 in breast cancer (BC). First, we describe the power of PDK1 in cellular behaviors and characterize the interaction networks of PDK1. Then, we establish the roles of PDK1 in carcinogenesis, growth and survival, metastasis, and chemoresistance in BC cells. More importantly, we sort the current preclinical or clinical trials of PDK1-targeted therapy in BC and find that, even though no selective PDK1 inhibitor is currently available for BC therapy, the combination trials of PDK1-targeted therapy and other agents have provided some benefit. Thus, there is increasing anticipation that PDK1-targeted therapy will have its space in future therapeutic approaches related to BC, and we hope the novel approaches of targeted therapy will be conducive to ameliorating the dismal prognosis of BC patients.
first_indexed 2024-03-10T00:05:17Z
format Article
id doaj.art-6c0ae5d7323242dd9ce91b97fbafceec
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T00:05:17Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-6c0ae5d7323242dd9ce91b97fbafceec2023-11-23T16:09:03ZengMDPI AGCancers2072-66942022-02-0114381110.3390/cancers14030811The Landscape of PDK1 in Breast CancerNa Wang0Jianjiang Fu1Zhihua Li2Ningni Jiang3Yanhong Chen4Juan Peng5Department of Pathology, Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, ChinaDepartment of Pathology, Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, ChinaDepartment of Pathology, Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, ChinaDepartment of Pathology, Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, ChinaDepartment of Pathology, Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, ChinaDepartment of Pathology, Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, ChinaGiven that 3-phosphoinositide-dependent kinase 1 (PDK1) plays a crucial role in the malignant biological behaviors of a wide range of cancers, we review the influence of PDK1 in breast cancer (BC). First, we describe the power of PDK1 in cellular behaviors and characterize the interaction networks of PDK1. Then, we establish the roles of PDK1 in carcinogenesis, growth and survival, metastasis, and chemoresistance in BC cells. More importantly, we sort the current preclinical or clinical trials of PDK1-targeted therapy in BC and find that, even though no selective PDK1 inhibitor is currently available for BC therapy, the combination trials of PDK1-targeted therapy and other agents have provided some benefit. Thus, there is increasing anticipation that PDK1-targeted therapy will have its space in future therapeutic approaches related to BC, and we hope the novel approaches of targeted therapy will be conducive to ameliorating the dismal prognosis of BC patients.https://www.mdpi.com/2072-6694/14/3/811PDK1breast cancersurvivalprognosistargeted therapy
spellingShingle Na Wang
Jianjiang Fu
Zhihua Li
Ningni Jiang
Yanhong Chen
Juan Peng
The Landscape of PDK1 in Breast Cancer
Cancers
PDK1
breast cancer
survival
prognosis
targeted therapy
title The Landscape of PDK1 in Breast Cancer
title_full The Landscape of PDK1 in Breast Cancer
title_fullStr The Landscape of PDK1 in Breast Cancer
title_full_unstemmed The Landscape of PDK1 in Breast Cancer
title_short The Landscape of PDK1 in Breast Cancer
title_sort landscape of pdk1 in breast cancer
topic PDK1
breast cancer
survival
prognosis
targeted therapy
url https://www.mdpi.com/2072-6694/14/3/811
work_keys_str_mv AT nawang thelandscapeofpdk1inbreastcancer
AT jianjiangfu thelandscapeofpdk1inbreastcancer
AT zhihuali thelandscapeofpdk1inbreastcancer
AT ningnijiang thelandscapeofpdk1inbreastcancer
AT yanhongchen thelandscapeofpdk1inbreastcancer
AT juanpeng thelandscapeofpdk1inbreastcancer
AT nawang landscapeofpdk1inbreastcancer
AT jianjiangfu landscapeofpdk1inbreastcancer
AT zhihuali landscapeofpdk1inbreastcancer
AT ningnijiang landscapeofpdk1inbreastcancer
AT yanhongchen landscapeofpdk1inbreastcancer
AT juanpeng landscapeofpdk1inbreastcancer